A first-of-its-kind device for pancreatic cancer treatment has been approved by the U.S. Food and Drug Administration.

The FDA has approved a first-of-its-kind portable, noninvasive device that delivers alternating electrical fields for the treatment of locally advanced pancreatic cancer.Optune Pax (Novocure) releases ...

The FDA approved Optune Pax (Novocure), a first-in-class portable device that delivers tumor-treating fields (TTFields) to the abdomen in adult patients with locally advanced pancreatic cancer, ...

A team of doctors at Michigan Medicine have successfully treated a child in severe septic shock and multiorgan failure with their newly created therapeutic tool called the selective cytopheretic ...

Nikki Szanyi is a small business field and startup manager at CDW, focusing on comprehensive go-to-market strategies and sales processes. For investor-backed startups racing to bring products to ...

Successful new medical devices hinge on the designer’s understanding of the specific requirements of the procedures they support, including factors like usage frequency and duration. This is ...

First approved therapy for locally advanced disease in almost three decades ...

The U.S. Food and Drug Administration has approved a first-of-its-kind device for the treatment of adult patients with locally advanced pancreatic cancer. Optune Pax, developed by Novocure, is a ...